ACHIKO AG
Achiko AG
/ Key word(s): Miscellaneous
Achiko AG – Investor Briefing Zurich, 7 July 2022: Achiko AG(SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”), would like to invite investors and shareholders to a moderated investor call. A powerpoint presentation will be available around the time of the call and published on the website. Details are as follows:
Date: 8 July 2022
Meeting link: https://us02web.zoom.us/j/6191486127?pwd=VWJYa0VmWFV3OTBiL1RDd0o5NjR2dz09 Find your local number: https://us02web.zoom.us/u/knHHcenwR
Achiko AG (SIX: ACHI.SW; OTCQB: ACHKF;www.achiko.com) is developing disruptive diagnostic solutions that puts people first. The company’s lead product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. The test and companion app were launched in Indonesia in mid-2021 and an application for CE Mark approval in Europe will be submitted in 2022. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameXTM and companion health apps via its digital mobile health technology division, Teman SehatTM. The AptameX DNA aptamer tests can be rapidly chemically synthesised, are cost-effective and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field. Headquartered in Zurich, Achiko has offices in Jakarta, and staff around the world. Media contacts: ACHIKO AG Switzerland & Global
Disclaimer Thiscommunicationexpresslyorimplicitlycontainscertainforward-lookingstatementsconcerningAchikoAG and its business. Such statements involve certain known and unknown risks, uncertainties and otherfactors, which could cause the actual results, financial condition, performance or achievements ofAchikoAG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Achiko AG is providing this communication as of this date and does notundertaketoupdateanyforward-lookingstatementscontainedhereinasaresultofnewinformation, future events or otherwise.
End of Media Release |
| Language: | English |
| Company: | Achiko AG |
| Tessinerplatz 7 | |
| 8002 Zurich | |
| Switzerland | |
| E-mail: | ir@achiko.com |
| Internet: | https://www.achiko.com/ |
| ISIN: | CH0522213468 |
| Valor: | 48788430 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 1393507 |
| End of News | EQS News Service |
1393507 07.07.2022
